These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 25873730)

  • 81. Long-term outcomes after invasive management for older patients with non-ST-segment elevation myocardial infarction.
    Roe MT; Li S; Thomas L; Wang TY; Alexander KP; Ohman EM; Peterson ED
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):323-32. PubMed ID: 23652734
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Immediate multivessel revascularization may increase cardiac death and myocardial infarction in patients with ST-elevation myocardial infarction and multivessel coronary artery disease: data analysis from real world practice.
    Chung WY; Seo JB; Choi DH; Cho YS; Lee JM; Suh JW; Youn TJ; Chae IH; Choi DJ
    Korean J Intern Med; 2016 May; 31(3):488-500. PubMed ID: 27048252
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Culprit-only versus staged complete revascularization for patients with ST-segment elevation myocardial infarction and Multivessel disease: a retrospective cohort study.
    Yu T; Dong Y; Zhu J; Tian C; Sun Z; Sun Z
    BMC Cardiovasc Disord; 2016 Oct; 16(1):189. PubMed ID: 27716075
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Complete revascularisation in ST-elevation myocardial infarction and multivessel disease: meta-analysis of randomised controlled trials.
    Kowalewski M; Schulze V; Berti S; Waksman R; Kubica J; Kołodziejczak M; Buffon A; Suryapranata H; Gurbel PA; Kelm M; Pawliszak W; Anisimowicz L; Navarese EP
    Heart; 2015 Aug; 101(16):1309-17. PubMed ID: 26037102
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Safety and efficacy of high- versus low-dose aspirin after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
    Yu J; Mehran R; Dangas GD; Claessen BE; Baber U; Xu K; Parise H; Fahy M; Lansky AJ; Witzenbichler B; Grines CL; Guagliumi G; Kornowski R; Wöhrle J; Dudek D; Weisz G; Stone GW
    JACC Cardiovasc Interv; 2012 Dec; 5(12):1231-8. PubMed ID: 23257371
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion-Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease.
    Marino M; Crimi G; Leonardi S; Ferlini M; Repetto A; Camporotondo R; Demarchi A; De Pascali I; Falcinella F; Oltrona Visconti L; De Servi S; Ferrario M; De Ferrari GM; Gnecchi M
    Am J Cardiol; 2017 Feb; 119(4):508-514. PubMed ID: 28007297
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effects of patient characteristics on the efficacy of complete revascularization for treatment of ST-segment elevation myocardial infarction with multivessel disease: A meta-analysis.
    Li LF; Qiu M; Liu SY; Zhou HR
    Medicine (Baltimore); 2021 Jun; 100(25):e26251. PubMed ID: 34160388
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 trials (FIR).
    Damman P; Wallentin L; Fox KA; Windhausen F; Hirsch A; Clayton T; Pocock SJ; Lagerqvist B; Tijssen JG; de Winter RJ
    Circulation; 2012 Jan; 125(4):568-76. PubMed ID: 22199015
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis.
    Vlaar PJ; Mahmoud KD; Holmes DR; van Valkenhoef G; Hillege HL; van der Horst IC; Zijlstra F; de Smet BJ
    J Am Coll Cardiol; 2011 Aug; 58(7):692-703. PubMed ID: 21816304
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Percutaneous coronary intervention of unprotected left main coronary artery disease as culprit lesion in patients with acute myocardial infarction.
    Pappalardo A; Mamas MA; Imola F; Ramazzotti V; Manzoli A; Prati F; El-Omar M
    JACC Cardiovasc Interv; 2011 Jun; 4(6):618-26. PubMed ID: 21700247
    [TBL] [Abstract][Full Text] [Related]  

  • 91. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
    Vink MA; Dirksen MT; Suttorp MJ; Tijssen JG; van Etten J; Patterson MS; Slagboom T; Kiemeneij F; Laarman GJ
    JACC Cardiovasc Interv; 2011 Jan; 4(1):24-9. PubMed ID: 21251625
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Usefulness of local delivery of thrombolytics before thrombectomy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (the delivery of thrombolytics before thrombectomy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention [DISSOLUTION] randomized trial).
    Greco C; Pelliccia F; Tanzilli G; Tinti MD; Salenzi P; Cicerchia C; Schiariti M; Franzoni F; Speziale G; Gallo P; Gaudio C
    Am J Cardiol; 2013 Sep; 112(5):630-5. PubMed ID: 23711809
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial.
    Mehta SR; Wang J; Wood DA; Spertus JA; Cohen DJ; Mehran R; Storey RF; Steg PG; Pinilla-Echeverri N; Sheth T; Bainey KR; Bangalore S; Cantor WJ; Faxon DP; Feldman LJ; Jolly SS; Kunadian V; Lavi S; Lopez-Sendon J; Madan M; Moreno R; Rao SV; Rodés-Cabau J; Stankovic G; Bangdiwala SI; Cairns JA;
    JAMA Cardiol; 2022 Nov; 7(11):1091-1099. PubMed ID: 36129696
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Sex-related Impact on Clinical Outcome of Everolimus-eluting Versus Bare-metal Stents in ST-segment Myocardial Infarction. Insights From the EXAMINATION Trial.
    Regueiro A; Fernández-Rodríguez D; Brugaletta S; Martín-Yuste V; Masotti M; Freixa X; Cequier Á; Íñiguez A; Serruys PW; Sabaté M;
    Rev Esp Cardiol (Engl Ed); 2015 May; 68(5):382-9. PubMed ID: 25444377
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Culprit only versus multivessel coronary revascularization in patients presenting with acute ST elevation myocardial infarction: unending debate.
    Celik T; Iyisoy A; Jata B; Kardesoglu E; Isik E
    Int J Cardiol; 2009 Sep; 137(1):65-6. PubMed ID: 18675476
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials for Multivessel PCI Versus Culprit Artery Only PCI in STEMI Without Cardiogenic Shock.
    Rai D; Tahir MW; Bandyopadhyay D; Chowdhury M; Kharsa A; Pendala VS; Ali H; Naidu SS; Baibhav B
    Curr Probl Cardiol; 2021 Mar; 46(3):100646. PubMed ID: 32650950
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Optimal Revascularization Strategy for Patients With ST-segment Elevation Myocardial Infarction and Multivessel Disease: A Pairwise and Network Meta-Analysis.
    Cui K; Yin D; Zhu C; Yuan S; Wu S; Feng L; Dou K
    Front Cardiovasc Med; 2021; 8():695822. PubMed ID: 35071337
    [No Abstract]   [Full Text] [Related]  

  • 98. Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial.
    Thiele H; Desch S; Piek JJ; Stepinska J; Oldroyd K; Serpytis P; Montalescot G; Noc M; Huber K; Fuernau G; de Waha S; Meyer-Saraei R; Schneider S; Windecker S; Savonitto S; Briggs A; Torremante P; Vrints C; Schuler G; Ceglarek U; Thiery J; Zeymer U;
    Am Heart J; 2016 Feb; 172():160-9. PubMed ID: 26856228
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Complete Revascularization in Patients With STEMI and Multi-Vessel Disease: A Meta-Analysis of Randomized Controlled Trials.
    Al-Abdouh A; Barbarawi M; Bizanti A; Abudaya I; Upadhrasta S; Elias H; Zhao D; Savji N; Lakshman H; Hasan R; Michos ED
    Cardiovasc Revasc Med; 2020 May; 21(5):684-691. PubMed ID: 32241726
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial.
    Gershlick AH; Khan JN; Kelly DJ; Greenwood JP; Sasikaran T; Curzen N; Blackman DJ; Dalby M; Fairbrother KL; Banya W; Wang D; Flather M; Hetherington SL; Kelion AD; Talwar S; Gunning M; Hall R; Swanton H; McCann GP
    J Am Coll Cardiol; 2015 Mar; 65(10):963-72. PubMed ID: 25766941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.